Allergan focuses on eye care, neurosciences, medical dermatology, medical aesthetics, etc. With 40 manufacturing facilities and 27 global R&D centers and marketing/sales facilities, the company operates in around 100 countries worldwide. In 2019, Allergan had approximately 17400 employees and a revenue of $16 Billion. In May 2020, AbbVie, US pharmaceutical company, acquired Allergan and is now domiciled in the U.S..
Allergan, which produces a wide range of healthcare products, is focused on people. But a near-constant stream of mergers and acquisitions was preventing the company from keeping an accurate, up-to-the-minute list of all current employees. The Denodo Platform changed that.
Keeping the Data Together
Allergan’s main challenge was that a significant number of terminated employees and contingent workers were still listed on a number of Active Directory (AD) databases, enabling them to access confidential information or even use their badges to access restricted areas. Not only did this present a security risk, but if the names of the terminated employees were not removed from the AD systems within 30 days, Allergan would fall out of compliance with SOX regulations, and risk having to pay significant penalties.
The Denodo Platform enabled the real-time integration of myriad heterogeneous, distributed, structured, and semi-structured data sources across Allergan’s holdings, regardless of where they were in the M&A process. The Denodo Platform enabled Allergan to quickly integrate and manage the critical data that was relevant to its business operations.
At a glance